{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:42:05Z","timestamp":1794552125645,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8130","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,9,3]]},"DOI":"10.1038\/s41586-026-10737-8","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:02:18Z","timestamp":1783522938000},"page":"262-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-genotoxic transplantation and in vivo selection through epitope editing"],"prefix":"10.1038","volume":"657","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-1195","authenticated-orcid":false,"given":"Gabriele","family":"Casirati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0378-6655","authenticated-orcid":false,"given":"Marta","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-4414","authenticated-orcid":false,"given":"Adele","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nola","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Carzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-3139","authenticated-orcid":false,"given":"Francesco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-7335","authenticated-orcid":false,"given":"Varun","family":"Katta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1637-6386","authenticated-orcid":false,"given":"Azusa","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5791-096X","authenticated-orcid":false,"given":"Yichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9190-6590","authenticated-orcid":false,"given":"Mohammed S.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Ch\u00e1vez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Manis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-3993","authenticated-orcid":false,"given":"Shengdar","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-0508","authenticated-orcid":false,"given":"Danilo","family":"Pellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-7945","authenticated-orcid":false,"given":"Daniel","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-9003","authenticated-orcid":false,"given":"Pietro","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"10737_CR1","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1182\/blood-2019-126325","volume":"134","author":"JA Fein","year":"2019","unstructured":"Fein, J. A. et al. Early organ toxicity following allogeneic hematopoietic stem cell transplantation differs by conditioning regimen. Blood 134, 4489\u20134489 (2019).","journal-title":"Blood"},{"key":"10737_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza, B. & Sandmaier, B. M. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 124, 344 (2014).","journal-title":"Blood"},{"key":"10737_CR3","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1038\/bcj.2011.14","volume":"1","author":"B Mohty","year":"2011","unstructured":"Mohty, B. & Mohty, M. Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update. Blood Cancer J. 1, e16\u2013e16 (2011).","journal-title":"Blood Cancer J."},{"key":"10737_CR4","doi-asserted-by":"publisher","first-page":"e0204914","DOI":"10.1371\/journal.pone.0204914","volume":"13","author":"S Hierlmeier","year":"2018","unstructured":"Hierlmeier, S., Eyrich, M., W\u00f6lfl, M., Schlegel, P. G. & Wiegering, V. Early and late complications following hematopoietic stem cell transplantation in pediatric patients \u2013 a retrospective analysis over 11 years. PLoS ONE 13, e0204914 (2018).","journal-title":"PLoS ONE"},{"key":"10737_CR5","doi-asserted-by":"publisher","first-page":"351ra105","DOI":"10.1126\/scitranslmed.aae0501","volume":"8","author":"A Chhabra","year":"2016","unstructured":"Chhabra, A. et al. Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy. Sci. Transl. Med. 8, 351ra105 (2016).","journal-title":"Sci. Transl. Med."},{"key":"10737_CR6","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1182\/blood-2010-07-295949","volume":"116","author":"X Xue","year":"2010","unstructured":"Xue, X. et al. Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice. Blood 116, 5419\u20135422 (2010).","journal-title":"Blood"},{"key":"10737_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.1149726","volume":"318","author":"A Czechowicz","year":"2007","unstructured":"Czechowicz, A., Kraft, D., Weissman, I. L. & Bhattacharya, D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318, 1296\u20131299 (2007).","journal-title":"Science"},{"key":"10737_CR8","doi-asserted-by":"publisher","first-page":"17832","DOI":"10.1073\/pnas.1317118110","volume":"110","author":"AV Reshetnyak","year":"2013","unstructured":"Reshetnyak, A. V. et al. Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region. Proc. Natl Acad. Sci. USA 110, 17832\u201317837 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10737_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood.V79.2.338.338","volume":"79","author":"VC Broudy","year":"1992","unstructured":"Broudy, V. C. et al. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 79, 338\u2013346 (1992).","journal-title":"Blood"},{"key":"10737_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"10737_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"10737_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver, M. C. et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527, 192\u2013197 (2015).","journal-title":"Nature"},{"key":"10737_CR13","first-page":"253","volume":"342","author":"DE Bauer","year":"2013","unstructured":"Bauer, D. E. et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science (1979). 342, 253\u2013257 (2013).","journal-title":"Science (1979)."},{"key":"10737_CR14","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan, E. A. Hematopoietic stem-cell transplantation. New Engl. J. Med. 354, 1813\u20131826 (2006).","journal-title":"New Engl. J. Med."},{"key":"10737_CR15","doi-asserted-by":"publisher","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","volume":"29","author":"JJ Auletta","year":"2023","unstructured":"Auletta, J. J. et al. Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research. Transplant. Cell. Ther. 29, 346.e1\u2013346.e10 (2023).","journal-title":"Transplant. Cell. Ther."},{"issue":"549","key":"10737_CR16","first-page":"570","volume":"30","author":"S Ferrari","year":"2023","unstructured":"Ferrari, S. et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell 30, 570 (2023).","journal-title":"Cell Stem Cell"},{"key":"10737_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","volume":"28","author":"PJ Martin","year":"2010","unstructured":"Martin, P. J. et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J. Clin. Oncol. 28, 1011\u20131016 (2010).","journal-title":"J. Clin. Oncol."},{"key":"10737_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","volume":"11","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi, F. et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front. Immunol. 11, 489 (2020).","journal-title":"Front. Immunol."},{"key":"10737_CR19","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Acute graft-versus-host disease \u2014 biologic process, prevention, and therapy. New Engl. J. Med. 377, 2167\u20132179 (2017).","journal-title":"New Engl. J. Med."},{"key":"10737_CR20","doi-asserted-by":"crossref","unstructured":"Nagler, A. & Shimoni, A. in The EBMT Handbook (eds Carreras, E. et al.) 99\u2013107 (Springer, 2019).","DOI":"10.1007\/978-3-030-02278-5_13"},{"key":"10737_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1046\/j.1365-2133.2003.05336.x","volume":"148","author":"E Vargas-D\u00edez","year":"2003","unstructured":"Vargas-D\u00edez, E., Fern\u00e1ndez-Herrera, J., Marin, A., C\u00e1mara, R. & Garc\u00eda-D\u00edez, A. Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation. Br. J. Dermatol. 148, 1129\u20131134 (2003).","journal-title":"Br. J. Dermatol."},{"key":"10737_CR22","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1182\/bloodadvances.2018024844","volume":"2","author":"S Chhabra","year":"2018","unstructured":"Chhabra, S. et al. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2, 2922\u20132936 (2018).","journal-title":"Blood Adv."},{"key":"10737_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09508-z","volume":"10","author":"A Czechowicz","year":"2019","unstructured":"Czechowicz, A. et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nat. Commun. 10, 1526 (2019).","journal-title":"Nat. Commun."},{"key":"10737_CR24","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41375-020-0818-9","volume":"34","author":"R Myburgh","year":"2020","unstructured":"Myburgh, R. et al. Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells. Leukemia 34, 2688\u20132703 (2020).","journal-title":"Leukemia"},{"key":"10737_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ymthe.2018.03.003","volume":"26","author":"Y Arai","year":"2018","unstructured":"Arai, Y. et al. Myeloid conditioning with c-kit-targeted CAR-T cells enables donor stem cell engraftment. Mol. Ther. 26, 1181\u20131197 (2018).","journal-title":"Mol. Ther."},{"key":"10737_CR26","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.bbmt.2018.12.101","volume":"25","author":"BR Pearse","year":"2019","unstructured":"Pearse, B. R. et al. A CD117-amanitin antibody drug conjugate (ADC) effectively depletes human and non-human primate hematopoietic stem and progenitor cells (HSPCs): targeted non-genotoxic conditioning for bone marrow transplant. Biol. Blood Marrow Transplant. 25, S29\u2013S30 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10737_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nbt.3584","volume":"34","author":"R Palchaudhuri","year":"2016","unstructured":"Palchaudhuri, R. et al. Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin. Nat. Biotechnol. 34, 738\u2013745 (2016).","journal-title":"Nat. Biotechnol."},{"key":"10737_CR28","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood-2018-99-116851","volume":"132","author":"M Srikanthan","year":"2018","unstructured":"Srikanthan, M. et al. Non-genotoxic conditioning efficiently depletes host hematopoietic stem cells and facilitates robust multi-lineage engraftment in a mouse model of Fanconi anemia. Blood 132, 2041\u20132041 (2018).","journal-title":"Blood"},{"key":"10737_CR29","doi-asserted-by":"publisher","first-page":"eaan0820","DOI":"10.1126\/scitranslmed.aan0820","volume":"9","author":"G Schiroli","year":"2017","unstructured":"Schiroli, G. et al. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Sci. Transl. Med. 9, eaan0820 (2017).","journal-title":"Sci. Transl. Med."},{"key":"10737_CR30","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41591-025-03817-1","volume":"31","author":"R Agarwal","year":"2025","unstructured":"Agarwal, R. et al. rradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial. Nat. Med. 31, 3183\u20133190 (2025).","journal-title":"Nat. Med."},{"key":"10737_CR31","doi-asserted-by":"publisher","first-page":"923.e1","DOI":"10.1016\/j.jtct.2024.07.001","volume":"30","author":"D Jung","year":"2024","unstructured":"Jung, D., Long-Boyle, J. R., Pang, W. W. & Gobburu, J. V. S. Pharmacokinetics of briquilimab as a conditioning agent for hematopoietic stem cell transplantation in patients with severe combined immunodeficiency, myelodysplastic syndrome, or acute myeloid leukemia. Transplant. Cell. Ther. 30, 923.e1\u2013923.e9 (2024).","journal-title":"Transplant. Cell. Ther."},{"key":"10737_CR32","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1182\/blood-2022-162406","volume":"140","author":"P Westervelt","year":"2022","unstructured":"Westervelt, P. et al. Mgta-117, an anti-CD117 antibody\u2013drug conjugated with amanitin, in participants with relapsed\/refractory adult acute myeloid leukemia (AML) and myelodysplasia with excess blasts (MDS-EB): safety, pharmacokinetics and pharmacodynamics initial findings from a phase 1\/2 study. Blood 140, 2117\u20132119 (2022).","journal-title":"Blood"},{"key":"10737_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607926","author":"A Villa","year":"2020","unstructured":"Villa, A., Capo, V. & Castiello, M. C. Innovative cell-based therapies and conditioning to cure RAG deficiency. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.607926 (2020).","journal-title":"Front. Immunol."},{"key":"10737_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/chim.15057","volume":"2","author":"M Andreani","year":"2011","unstructured":"Andreani, M., Testi, M., Battarra, M. & Lucarelli, G. Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies. Chimerism 2, 21\u201322 (2011).","journal-title":"Chimerism"},{"key":"10737_CR35","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","volume":"130","author":"CD Fitzhugh","year":"2017","unstructured":"Fitzhugh, C. D. et al. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood 130, 1946\u20131948 (2017).","journal-title":"Blood"},{"key":"10737_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41586-023-06496-5","volume":"621","author":"G Casirati","year":"2023","unstructured":"Casirati, G. et al. Epitope editing enables targeted immunotherapies for acute myeloid leukemia. Nature 621, 404\u2013414 (2023).","journal-title":"Nature"},{"key":"10737_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","volume":"390","author":"F Locatelli","year":"2024","unstructured":"Locatelli, F. et al. Exagamglogene autotemcel for transfusion-dependent \u03b2-thalassemia. New Engl. J. Med. 390, 1663\u20131676 (2024).","journal-title":"New Engl. J. Med."},{"key":"10737_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2024.11.001","volume":"32","author":"J Zeng","year":"2025","unstructured":"Zeng, J. et al. Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells. Cell Stem Cell 32, 191\u2013208.e11 (2025).","journal-title":"Cell Stem Cell"},{"key":"10737_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1182\/blood-2023-185533","volume":"142","author":"A Gandhi","year":"2023","unstructured":"Gandhi, A. et al. Final results from phase 1 study of briquilimab, an anti-CD117 monoclonal antibody, in combination with low dose irradiation and fludarabine conditioning, shows durable remissions in older adults with acute myeloid leukemia in complete remission and myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation. Blood 142, 470 (2023).","journal-title":"Blood"},{"key":"10737_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2024-200214","volume":"144","author":"M Hsieh","year":"2024","unstructured":"Hsieh, M. et al. Adding CD117 antibody to alemtuzumab, low dose total body irradiation (TBI), and sirolimus for matched related donor (MRD) hematopoietic cell transplant (HCT) in sickle cell disease (SCD): initial results. Blood 144, 1141\u20131141 (2024).","journal-title":"Blood"},{"key":"10737_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-024-07259-6","volume":"628","author":"J Yan","year":"2024","unstructured":"Yan, J. et al. Improving prime editing with an endogenous small RNA-binding protein. Nature 628, 639\u2013647 (2024).","journal-title":"Nature"},{"key":"10737_CR42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41587-024-02266-4","volume":"43","author":"S Levesque","year":"2024","unstructured":"Levesque, S., Cosentino, A., Verma, A., Genovese, P. & Bauer, D. E. Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism. Nat. Biotechnol. 43, 534\u2013538 (2024).","journal-title":"Nat. Biotechnol."},{"key":"10737_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2014","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2014).","journal-title":"Nat. Biotechnol."},{"key":"10737_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02948-7","author":"CR Lazzarotto","year":"2026","unstructured":"Lazzarotto, C. R. et al. Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02948-7 (2026).","journal-title":"Nat. Biotechnol."},{"key":"10737_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).","journal-title":"Genome Biol."},{"key":"10737_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4561-9","volume":"19","author":"G Giannoukos","year":"2018","unstructured":"Giannoukos, G. et al. UDiTaS, a genome editing detection method for indels and genome rearrangements. BMC Genomics 19, 212 (2018).","journal-title":"BMC Genomics"},{"key":"10737_CR47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2022-158684","volume":"140","author":"N Wellhausen","year":"2022","unstructured":"Wellhausen, N. et al. Epitope editing in hematopoietic cells enables CD45-directed immune therapy. Blood 140, 862\u2013864 (2022).","journal-title":"Blood"},{"key":"10737_CR48","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-07456-3","volume":"630","author":"S Garaud\u00e9","year":"2024","unstructured":"Garaud\u00e9, S. et al. Selective haematological cancer eradication with preserved haematopoiesis. Nature 630, 728\u2013735 (2024).","journal-title":"Nature"},{"key":"10737_CR49","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","volume":"185","author":"A Omer-Javed","year":"2022","unstructured":"Omer-Javed, A. et al. Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells. Cell 185, 2248\u20132264.e21 (2022).","journal-title":"Cell"},{"key":"10737_CR50","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1182\/blood-2018-06-853879","volume":"133","author":"HS Kwon","year":"2019","unstructured":"Kwon, H. S. et al. Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice. Blood 133, 2104\u20132108 (2019).","journal-title":"Blood"},{"key":"10737_CR51","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood-2021-153074","volume":"138","author":"R Agarwal","year":"2021","unstructured":"Agarwal, R. et al. JSP191 as a single-agent conditioning regimen results in successful engraftment, donor myeloid chimerism, and production of donor derived na\u00efve lymphocytes in patients with severe combined immunodeficiency (SCID). Blood 138, 554\u2013554 (2021).","journal-title":"Blood"},{"key":"10737_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08201-x","volume":"10","author":"A Czechowicz","year":"2019","unstructured":"Czechowicz, A. et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nat. Commun. 10, 617 (2019).","journal-title":"Nat. Commun."},{"key":"10737_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41153-5","volume":"14","author":"N Uchida","year":"2023","unstructured":"Uchida, N. et al. Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model. Nat. Commun. 14, 6291 (2023).","journal-title":"Nat. Commun."},{"key":"10737_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/cgt.2012.25","volume":"19","author":"JL Gori","year":"2012","unstructured":"Gori, J. L., Beard, B. C., Ironside, C., Karponi, G. & Kiem, H. P. In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog model. Cancer Gene Ther. 19, 523\u2013529 (2012).","journal-title":"Cancer Gene Ther."},{"key":"10737_CR55","doi-asserted-by":"publisher","first-page":"133ra57","DOI":"10.1126\/scitranslmed.3003425","volume":"4","author":"JE Adair","year":"2012","unstructured":"Adair, J. E. et al. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci. Transl. Med. 4, 133ra57 (2012).","journal-title":"Sci. Transl. Med."},{"key":"10737_CR56","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul, H. et al. Exagamglogene autotemcel for severe sickle cell disease. New Engl. J. Med. 390, 1649\u20131662 (2024).","journal-title":"New Engl. J. Med."},{"key":"10737_CR57","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2024-200875","volume":"144","author":"PS Chockalingam","year":"2024","unstructured":"Chockalingam, P. S. et al. Impact of BEAM-101 treatment on red blood cell hemoglobin expression, rheology and sickling properties: initial data from the BEACON phase 1\/2 study of autologous CD34+ base edited hematopoietic stem cells in sickle cell disease. Blood 144, 4957\u20134957 (2024).","journal-title":"Blood"},{"key":"10737_CR58","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/bloodadvances.2024015574","volume":"9","author":"Y Jang","year":"2025","unstructured":"Jang, Y. et al. BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice. Blood Adv. 9, 2722\u20132732 (2025).","journal-title":"Blood Adv."},{"key":"10737_CR59","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nprot.2017.143","volume":"13","author":"RO Bak","year":"2018","unstructured":"Bak, R. O., Dever, D. P. & Porteus, M. H. CRISPR\/Cas9 genome editing in human hematopoietic stem cells. Nat. Protoc. 13, 358\u2013376 (2018).","journal-title":"Nat. Protoc."},{"key":"10737_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"10737_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-0716-2879-9_5","volume":"2606","author":"J Zeng","year":"2023","unstructured":"Zeng, J., Casirati, G., Nguyen, M. A., Genovese, P. & Bauer, D. E. Base editing of human hematopoietic stem cells. Methods Mol. Biol. 2606, 43\u201362 (2023).","journal-title":"Methods Mol. Biol."},{"key":"10737_CR62","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1182\/blood-2009-10-249326","volume":"115","author":"F Notta","year":"2010","unstructured":"Notta, F., Doulatov, S. & Dick, J. E. Engraftment of human hematopoietic stem cells is more efficient in female NOD\/SCID\/IL-2Rgc-null recipients. Blood 115, 3704\u20133707 (2010).","journal-title":"Blood"},{"key":"10737_CR63","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/cyto.a.23148","volume":"91","author":"L Basso-Ricci","year":"2017","unstructured":"Basso-Ricci, L. et al. Multiparametric whole blood dissection: a one-shot comprehensive picture of the human hematopoietic system. Cytometry 91, 952 (2017).","journal-title":"Cytometry"},{"key":"10737_CR64","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","volume":"38","author":"CR Lazzarotto","year":"2020","unstructured":"Lazzarotto, C. R. et al. CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. Nat. Biotechnol. 38, 1317\u20131327 (2020).","journal-title":"Nat. Biotechnol."},{"key":"10737_CR65","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245 (2018).","journal-title":"Nucleic Acids Res."},{"key":"10737_CR66","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","volume":"7","author":"KA Everette","year":"2023","unstructured":"Everette, K. A. et al. Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nat. Biomed. Eng. 7, 616\u2013628 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"10737_CR67","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1016\/j.ymthe.2024.07.022","volume":"32","author":"V Katta","year":"2024","unstructured":"Katta, V. et al. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease. Mol. Ther. 32, 3433\u20133452 (2024).","journal-title":"Mol. Ther."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10737-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10737-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10737-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:01:47Z","timestamp":1788386507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10737-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":67,"journal-issue":{"issue":"8130","published-print":{"date-parts":[[2026,9,3]]}},"alternative-id":["10737"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10737-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.C., A.C. and P.G. are inventors of patent applications related to this work (WO2023159136A2 and WO2024148235A1), which are owned and managed by the Boston Children\u2019s Hospital and Dana-Farber Cancer Institute. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}